What Clinicians Need to Know About Johnson & Johnson’s Janssen COVID-19 Vaccine

On April 13, 2021, CDC and FDA recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 Vaccine. Of the nearly 7 million doses administered so far in the United States, a small number of  cases of a rare and severe type of blood clot have been reported in people after receiving the J&J/Janssen COVID-19 Vaccine.  All reports occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination. As of April 13, 2021, no cases have been reported among the more than 180 million people who received the Pfizer-BioNTech or Moderna vaccines. For further information, please see CDC Health Alert Network (HAN) Health Alert 442.

“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention. ”

The fully captioned video and edited transcript will be posted within the next few days.

alert icon

This COCA Call will be held on Friday, March 27, 2020

Overview

This COCA Call will give clinicians an overview of the J&J Janssen COVID-19 vaccine. Clinicians will learn about vaccine characteristics and administration, vaccinating special populations, and contraindications. They will also get answers to a number of clinical questions CDC has received about this new vaccine.

Presenters

Sarah Mbaeyi, MD, MPH
CDR, U.S. Public Health Service
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Sara Oliver, MD
LCDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Kathleen Dooling, MD, MPH
Medical Officer
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Facebook Live icon

Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.

Call Details

When:
Tuesday, March 2, 2021,
2:00 PM – 3:00 PM ET

Webinar Link:
https://www.zoomgov.com/j/1603748312?pwd=anlmUURkSEtmdzBLSmNOV0pJSzZUQT09external icon

Passcode: 893944

Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590

International numbersexternal icon

iPhone one-tap:
US: +16692545252,,1603748312#,,,,*893944#  or +16468287666,,1603748312#,,,,*893944#

Webinar ID: 160 374 8312

Add to Calendar
Sign up for COCA Newsletters and Announcements

Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address:

Page last reviewed: September 4, 2020